Japanese quail were administered 100 mg/kg chlorophenyl-labeled [UC] fenvalerate, a-cyano-3phenoxybenzyl 2-(4-chlorophenyl)isovalerate, for study of its distribution, elimination, and metabolism. Ninety percent of the administered dose was eliminated in the excreta within the first 24 h. In addition to fenvalerate, the following metabolites were present: benzeneacetic acid, 4-chloro-a-(l-methylethyl)-, cyano(3-phenoxy-4-hydroxyphenyl)methyl ester [4'-OH-fenvalerate]; benzeneacetic acid, 4-chloro-a-(1-methylethyl)-, (aminocarbonyl)(3-phenoxyphenyl)methyl ester [CONH2-fenvalerate]; 4-chloro-a-(lmethylethyl)benzeneacetic acid [Cl-V acid]; 4-chloro-a-(2-hydroxy-1-methylethyl)benzeneacetic acid [4-OH-C1-V acid].In time course studies radiocarbon peaked at 3 h (9 pg/g) in the liver and gradually declined, while in the blood it peaked within 2 h and fell quickly to an equilibrium value of 1.5 pg/mL blood. In liver microsomal and isolated heptatocyte preparations of Japanese quail and rat, the following metabolites were identified: Cl-V acid, 4-OH-C1-V acid, 4'-OH-fenvalerate, CONH2-fenvalerate. Oxidation was found to be the predominant route of degradation either pre-or posthydrolysis of the parent compound. Rapid excretion, lesser absorption, and faster metabolism probably explain the lower toxicity of fenvalerate to birds compared to rats.